مرض القلب التاجي
مصادر ومراجع

study of the causes of "natural" sudden death
Heart Association: Heart Disease and Stroke Statistics
Heart Disease and Stroke Statistics-2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee - Rosamond et al. 115 (5): e69 - Circulation
Shaw, L.J., Merz, C.N.B., Pepine, C.J., MD, Reis, S.E., Bittner, V., Kelsey, Olson, M., Johnson, D., Mankad, S., Sharaf, B.L., Rogers W.J., Wessel, T.R., Arant, C.B., Pohost, G.M., Lerman, A., Quyyumi, A.A., Sopko, G.: Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study. Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies. J Am Coll Cardiol 47: 4S–20S, 2006
Merz, C.N.B., Shaw, L.J., Reis, S.E., Bittner, V., Kelsey, S.F., Olson, M., Johnson, D., Pepine, C.J., Mankad, S., Sharaf, B.L., Rogers, W.J., Pohost, G.M., Lerman, A., Quyyumi, A.A., Sopko, G.: Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study. Part II: Gender Differences in Presentation, Diagnosis, and Outcome With Regard to Gender-Based Pathophysiology of Atherosclerosis and Macrovascular and Microvascular Coronary Disease. J Am Coll Cardiol 47: 21S–29S, 2006
Lanza, G.A.: Cardiac syndrome X: A critical overview and future perspectives. Heart 93:159-166, 2007
Kaski, J.C.: Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 109: 568-572, 2004
Stegmann, T.J.: New Vessels for the Heart. Angiogenesis as New Treatment for Coronary Heart Disease: The Story of its Discovery and Development. Henderson, Nevada 89012, USA, 2004. ISBN 978-0-9765583-0-9
Stegmann, T.J.: Protein promise in heart disease. GCPj, March 2007, 21-24
Simon, Harvey B. (2002). The Harvard Medical School guide to men's health. New York: Free Press, 37-8.0-684-87181-5.
"Women and heart disease - includes related information on heart attack, gender bias in research, and tests for coronary artery disease.
5. Population nutrient intake goals for preventing diet-related chronic diseases
Geleijnse JM, Vermeer C, Grobbee DE, et al (2004). "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study". J. Nutr. 134 (11): 3100–5.15514282.
Erkkilä AT, Booth SL (2008). "Vitamin K intake and atherosclerosis". Curr. Opin. Lipidol. 19 (1): 39–42. 18196985.
Wallin R, Schurgers L, Wajih N (2008). "Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification". Thromb. Res..18234293.
Behavioral counseling in primary care to promote physical activity: recommendation and rationale" (2002). Ann. Intern. Med. 137 (3): 205-7. 12160370.
Thompson PD, Buchner D, Pina IL, et al (2003). "Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)". Circulation 107 (24): 3109-16.PMID 12821592
Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL. (1990). "Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.". Lancet 336 (8708): 129-33.1973470
Key TJ, Fraser GE, Thorogood M, Appleby PN, Beral V, Reeves G, Burr ML, Chang-Claude J, Frentzel-Beyme R, Kuzma JW, Mann J, McPherson K (1998). "Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76,000 men and women in five prospective studies.". Public Health Nutr 1 (1): 33-41.PMID 10555529
Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D. (1995). "Mediterranean diet pyramid: a cultural model for healthy eating.". Am J Clin Nutr 61 (6 Suppl): 1402S-1406S.7754995
Perez-Llamas, F., et.al., J Hum Nutr Diet, Dec 1996, 9:6:463-471
Alberti-Fidanza A, Paolacci CA, Chiuchiu MP, Coli R, Fruttini D, Verducci G, Fidanza F. (1994). "Dietary studies on two rural Italian population groups of the Seven Countries Study. 1. Food and nutrient intake at the thirty-first year follow-up in 1991.". Eur J Clin Nutr 48 (2): 85-91. PMID 8194497
Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB. (2005). "Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction.". J Nutr 135 (3): 562-6.15735094.
Campbell CL, Smyth S, Montalescot G, Steinhubl SR (2007). "Aspirin dose for the prevention of cardiovascular disease: a systematic review". JAMA 297 (18): 2018-24.17488967.
Berger J, Roncaglioni M, Avanzini F, Pangrazzi I, Tognoni G, Brown D (2006). "Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials". JAMA 295 (3): 306-13. 16418466.
"Aspirin for the primary prevention of cardiovascular events: recommendation and rationale". (2002). Ann Intern Med 136 (2): 157-60.PMID 11790071
to Med-decisions!
Ridker P, Cook N, Lee I, Gordon D, Gaziano J, Manson J, Hennekens C, Buring J (2005). "A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women". N Engl J Med 352 (13): 1293-304.15753114.
Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update - Mosca et al., 10.1161/CIRCULATIONAHA.107.181546 - Circulation
Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins JP, Capps NE, Riemersma RA, Ebrahim SB, Davey Smith G (2006). "Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review". BMJ 332 (7544): 752-60.16565093
Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J (2006). "n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review". Am. J. Clin. Nutr. 84 (1): 5-17 PMID 16825676
Yokoyama M, Origasa H, Matsuzaki M, et al (2007). "Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis". Lancet 369 (9567): 1090-8.17398308.
Awtry, Eric H.; Joseph Loscalzo (2004). "Coronary Heart Disease", Cecil Essentials of Medicine, 6, Philadelphia, PA Saunders, 87-108.978-0-7216-0147-2.
Keller T, Squizzato A, Middeldorp S (2007). "Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease". Cochrane database of systematic reviews (Online) (3): CD005158.17636787.
Kasper, D.L., Braunwald, E., Fauci, A.S., Hauser, S.L., Longo, D.L., Jameson, J.L. (Eds.): Harrison's principles of internal medicine. 16th edition, McGraw-Hill, New York, 2005
Farrall M, Green FR, Peden JF, Olsson PG, Clarke R, Hellenius ML, Rust S, Lagercrantz J, Franzosi MG, Schulte H, Carey A, Olsson G, Assmann G, Tognoni G, Collins R, Hamsten A, Watkins H, on behalf of the PROCARDIS Consortium (2006). "Genome-Wide Mapping of Susceptibility to Coronary Artery Disease Identifies a Novel Replicated Locus on Chromosome 17".16710446.
Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, Manttari M, Frick MH, Huttunen JK. (1992). "Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.". Ann Intern Med 116 (4): 273-8.PMID 1733381.
Andraws R, Berger JS, Brown DL. (2005). "Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials.". JAMA 293 (21): 2641-7. 15928286.
Simons, M., Bonow, R.O., Chronos, N.A., Cohen, D.J., Giordano, F.J., Hammond, H.K., Laham, R.J., Li, W., Pike, M., Sellke, F.W., Stegmann, T.J., Udelson, J.E., Rosengart, T.K.: Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation. 2000; 102: E73-E86
Stegmann, T.J.: A human growth factor in the induction of neoangiogenesis. Exp.Opin.Invest.Drugs 7: 2011-2015, 1998
Wagoner, L.E., Merrill, W., Jacobs, J., Conway, G., Boehmer, J., Thomas, K., Stegmann, T.J.: Angiogenesis Protein Therapy With Human Fibroblast Growth Factor (FGF-1): Results Of A Phase I Open Label, Dose Escalation Study In Subjects With CAD Not Eligible For PCI Or CABG. Circulation 116: 443, 2007
↑  . PMID:24395629. {{استشهاد ويب}}: الوسيط |title= غير موجود أو فارغ (من ويكي بيانات) (مساعدة) والوسيط |مسار= غير موجود أو فارع (مساعدة)
↑  م.ط.م.  نسخة محفوظة 7 أبريل 2016 على موقع واي باك مشين.
رسم توضيحي للنوبة القلبيه